XERIS BIOPHARMA HOLDINGS INC
XERSNASDAQ🏆 #1867 by market capEarnings Nov 5US Equity
$736.80▲ $12.75 (+1.73%)
Simulated price1h—
24h▲ 1.7%
7d▲ 8973.9%
14d▲ 8692.4%
30d▲ 8940.5%
1y▲ 10020.9%
🏦Market Cap
$1.45B
Small Cap
📈Revenue Growth (YoY)
+41.5%
High Growth
📊Gross Margin
85.9%
High
💵FCF Margin
15.1%
Healthy
⚖️P/S Ratio
4.4x
Fair
Otter Score
55
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
-0.18
Expected
0.01
miss
−1582.70%
YoY −1700.00%
Revenue
Actual
$91.00M
Expected
$90.13M
beat
+1.00%
YoY +27.20%
Consensus estimates
Recent quarters
Q3 2026
-0.18
miss
Q2 2026
0.01
beat
Q1 2026
0.06
beat
Q4 2025
0.00
miss